The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation

British Journal of Haematology

Volumn 102, Issue 3, 1998, Pages 633-638

  Locatelli, Franco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Adoptive immunotherapy; Donor leucocyte infusion; Graft versus host disease; Graft versus leukaemia; Second bone marrow transplantation

Indexed keywords

ALPHA INTERFERON;

ADOPTIVE IMMUNOTHERAPY; BONE MARROW SUPPRESSION; GRAFT VERSUS HOST REACTION; LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT INDICATION;

ACUTE DISEASE; CHRONIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNIZATION; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA; LEUKOCYTE TRANSFUSION; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031865613     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00830.x     Document Type: Review

References (43)

1. Anderson, K.C. & Weinstein, H.J. (1990) Transfusion-associated graft-versus-host disease. New England Journal of Medicine, 233, 315-321.
2. Arcese, W., Mauro, F.R., Alimena, G., Lo Coco, F., De Cuia, M.R., Screnci, M., Iori, A.P., Montefusco, E. & Mandelli, F. (1990) Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplantation, 5, 309-315.
3. Barrett, A.J., Locatelli, F., Treleaven, J.G., Gratwohl, A., Szydlo, R. & Zwaan, F.E. (1991) Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party. British Journal of Haematology, 79, 567-574.
4. Barrett, A.J. & Malkovska, V. (1996) Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematological malignancies. British Journal of Haematology, 93, 754-761.
5. Barrett, A.J., Mavroudis, D., Molldrem, J., Read, E.J., Carter, C., Dunbar, C. & Young, N.S. (1996) Optimizing the dose and timing of lymphocytes add-back in T-cell-depleted BMT between HLA-identical siblings. Blood, 88, (Suppl. 1), 460a.
6. Bonini, C., Ferrari, G., Verzelletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C. & Bordignon, C. (1997) HSV-TK gene transfer into donor-lymphocytes for control of allogeneic graft-versus-leukemia. Science, 276, 1719-1724.
7. Bosi, A., Bacci, S., Miniero, R., Locatelli, R. Laszlo, D., Longo, G., Busca, A., van Lint, M.T., Di Bartolomeo, P. & Amici, A. (1997) Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo. Leukemia, 11, 420-424.
8. Cardoso, A.A., Schultze, J.L., Boussiotis, V.A., Freeman, G.J., Seamon, M.J., Laszlo, S., Billet, A., Sallan, S.E., Gribben, J.G. & Nadler, L.M. (1996) Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood, 88, 41-48.
9. Cardoso, A.A., Seamon, M.J., Afonso, H.M., Ghia, P., Boussiotis, V.A., Freeman, G.J., Gribben, J.G., Sallan, S.E. & Nadler, L.M. (1997) Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood, 90, 549-561.
10. Collins, R.H., J., Shpilberg, O., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J.H. & Nemunaitis, J. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 15, 433-444.
11. Comoli, P., Montagna, D., Moretta, A., Zecca, M., Locatelli, F. & Maccario, R. (1995) Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. Journal of Immunology, 155, 5506-5511.
12. Cullis, J.O., Schwarer, A.P., Hughes, T.P., Hows, J.M., Franklin, I., Morgenstern, G. & Goldman, J.M. (1992) Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning. British Journal of Haematology, 80, 33-39.
13. Dazzi, F., Raanani, P., van Rhee, P., Szydlo, R., Olavarria, E., Kaeda, J., Apperley, J.F., Cross, N.C.P. & Goldman, J.M. (1998) Donor lymphocyte infusion (DLI) for relapse of CML after allo-BMT: comparison of two regimens. Bone Marrow Transplantation, 21, (Suppl. 1), S70.
14. Faber, L.M., van-Luxemburg Heijs, S.A., Willemze, R. & Falkenburg, J.H. (1992) Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. Journal of Experimental Medicine, 176, 1283-1289.
15. Falkenburg, J.H., Smit, W.M. & Willemze, R. (1997a) Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunological Reviews, 157, 223-230.
16. Falkenburg, J.H., Wafelman, A.R., van Bergen, C.A.M., Bongaerts, R., Lurvink, E.G.A., Posthuma, E.F.M., Smit, W.M., Joosten, P., Landegent, J.E., Kluin-Nelemans, J.C., Fibbe, W.E. & Willemze, R. (1997b) Leukemia-reactive cytotoxic T lymphocytes (CTL) induce complete remission in a patient with refractory accelerated phase chronic myeloid leukemia (CML). Blood, 90, (Suppl. 1), 589a.
17. Frassoni, F., Barrett, A.J., Granena, A., Ernst, P., Garthon, G., Kolb, H.J., Prentice, H.G., Vernant, J.P., Zwaan, F.E. & Gratwohl, A. (1988) Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey of the EBMT of 117 cases. British Journal of Haematology, 70, 317-320.
18. Giralt, S., Hester, J., Huh, Y., Hirsch Ginsberg, C., Rondon, G., Seong, D., Lee, M., Gajewski, J., Van Besien, K., Khouri, I., Mehra, R., Przepiorka, D., Korbling, M., Talpaz, M., Kantarjian, H., Fischer, H., Deisseroth, A. & Champlin, R. (1995) CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood, 86, 4337-4343.
19. Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.P., Fernandez, M. & Chastang, C. (1997) Outcome of cord blood transplantation from related and unrelated donors. New England Journal of Medicine, 317, 373-381.
20. Goulmy, E. (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunological Reviews, 157, 125-140.
21. Guinan, E.C., Gribben, J.G., Boussiotis, V.A., Freeman, G.J. & Nadler, L.M. (1994) Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84, 3261-3282.
22. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
23. Johnson, B.D., Drobyski, W.R. & Truitt, L.R. (1993) Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemic reaction without graft-versus-host disease. Bone Marrow Transplantation, 11, 329-336.
24. Kolb, H.J., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M. & Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462-2465.
25. Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., van Rhee, F., Mittermuller, J., De Witte, T., Holler, E. & Ansari, H. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party in Chronic Leukemia. Blood, 86, 2041-2050.
26. Kwak, L.W., Taub, D.D., Duffey, P.L., Besinger, W.I., Bryant, E.M., Reynolds, C.W. & Longo, D.L. (1995) Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet, 345, 1016-1020.
27. Lin, F., Dazzi, F., Sohal, J., Szydlo, R.M., van Rhee, R., Reiter, A., Goldman, J. & Cross, N.C. (1997) The rate and kinetics of molecular response to donor leukocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. British Journal of Haematology, 99, 945-950.
28. Locatelli, F., Comoli, P., Giorgiani, G., Carrà, A.M., Di Giulio, G., Di Maggio, E.M., Pellegrini, N. & Maccario, R. (1997) Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukemia effect. Leukemia, 11, 729-731.
29. Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L.M. & Verdonck, L.F. (1997) Donor leukocyte infusion are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, 90, 4206-4211.
30. Mackinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., Castro Malaspina, H., Childs, B.H., Gillio, A.P., Kernan, N.A., Small, T.N., Young, J.W. & O'Reilly, R.J. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86, 1261-1268.
31. Mehta, J., Powles, R., Treleaven, J., Horton, C., Meller, S., Pinkerton, C.R. & Singhal, S. (1997) Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplantation, 19, 709-719.
32. Molldrem, J., Dermime, S., Parker, K., Jiang, Y.Z., Mavroudis, D., Hensel, N., Fukushima, P. & Barrett, A.J. (1996) Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood, 88, 2450-2457.
33. Mrsic, M., Horowitz, M.M., Atkinson, K., Biggs, J.C., Champlin, R.E., Ehninger, G., Gajewski, J.L., Gale, R.P., Herzig, R.H., Prentice, H.G., Rozman, C., Sobocinski, K.A., Speck, B. & Bortin, M.M. (1992) Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplantation, 9, 269-275.
34. Murphy, W.J. & Longo, D.L. (1997) The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. Immunological Reviews, 157, 167-176.
35. Porter, D.L., Roth, M.S., McGarigle, C., Ferrara, J.L. & Antin, J.H. (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New England Journal of Medicine, 330, 100-106.
36. Raanani, P., Dazzi, F., Sohal, J., Szydlo, R., van Rhee, F., Reiter, A., Lin, F., Goldman, J.M. & Cross, C.P. (1997) The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. British Journal of Haematology, 99, 945-950.
37. Radich, J.P., Sanders, J.E., Buckner, C.D., Martin, P.J., Petersen, F.B., Bensinger, W., McDonald, G.B., Mori, M., Schoch, G. & Hansen, J.A. (1993) Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. Journal of Clinical Oncology, 11, 304-313.
38. Sanders, J.E., Buckner, C.D., Clift, R.A., Fefer, A., McGuffin, R., Storb, R., Appelbaum, F., Bensinger, W., Beatty, P. & Doney, K. (1988) Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. Bone Marrow Transplantation, 3, 11-19.
39. Slavin, S., Ackerstein, A., Naparstek, E., Or, R. & Weiss, L. (1990) The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transplantation, 6, 155-161.
40. Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C. & Or, R. (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukaemia relapse after allogeneic bone marrow transplantation. Blood, 87, 2195-2204.
41. Truitt, R.L. & Atasoylu, A.A. (1991) Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood, 77, 2515-2523.
42. van Rhee, F., Lin, F., Cullis, J.O., Spencer, A., Cross, N.C., Chase, A., Garicochea, B., Bungey, J., Barrett, J. & Goldman, J.M. (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood, 83, 3377-3383.
43. Verdonck, L.F., Lokhorst, H.M., Dekker, A.W., Nieuwenhuis, H.K. & Petersen, E.J. (1996) Graft-versus-myeloma effect in two cases. Lancet, 347, 800-801.